{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:21:53Z","timestamp":1794277313766,"version":"4.9.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.1038\/10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["RO1AI42269"],"award-info":[{"award-number":["RO1AI42269"]}],"id":[{"id":"10.1038\/10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52617-7","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T13:03:44Z","timestamp":1727442224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["CD38 in SLE CD4 T cells promotes Ca2+ flux and suppresses interleukin-2 production by enhancing the expression of GM2 on the surface membrane"],"prefix":"10.1038","volume":"15","author":[{"given":"Eri","family":"Katsuyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Humbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Suarez-Fueyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhigyan","family":"Satyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7652-3826","authenticated-orcid":false,"given":"Vasileios C.","family":"Kyttaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-1358","authenticated-orcid":false,"given":"Maria G.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9589-2360","authenticated-orcid":false,"given":"George C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"52617_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med 365, 2110\u20132121 (2011).","journal-title":"N. Engl. J. Med"},{"key":"52617_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","volume":"21","author":"GC Tsokos","year":"2020","unstructured":"Tsokos, G. C. Autoimmunity and organ damage in systemic lupus erythematosus. Nat. Immunol. 21, 605\u2013614 (2020).","journal-title":"Nat. Immunol."},{"key":"52617_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0896-8411(91)90056-I","volume":"4","author":"J Alcocer-Varela","year":"1991","unstructured":"Alcocer-Varela, J., Alarcon-Riquelme, M., Laffon, A., Sanchez-Madrid, F. & Alarcon-Segovia, D. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2. J. Autoimmun. 4, 935\u2013945 (1991).","journal-title":"J. Autoimmun."},{"key":"52617_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13075-018-1578-z","volume":"20","author":"S Cole","year":"2018","unstructured":"Cole, S. et al. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther. 20, 85 (2018).","journal-title":"Arthritis Res Ther."},{"key":"52617_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/096120339700600905","volume":"6","author":"FM Erkeller-Yuksel","year":"1997","unstructured":"Erkeller-Yuksel, F. M., Lydyard, P. M. & Isenberg, D. A. Lack of NK cells in lupus patients with renal involvement. Lupus 6, 708\u2013712 (1997).","journal-title":"Lupus"},{"key":"52617_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13075-019-2001-0","volume":"21","author":"H Wang","year":"2019","unstructured":"Wang, H., Li, S., Zhang, G., Wu, H. & Chang, X. Potential therapeutic effects of cyanidin-3-O-glucoside on rheumatoid arthritis by relieving inhibition of CD38+ NK cells on Treg cell differentiation. Arthritis Res Ther. 21, 220 (2019).","journal-title":"Arthritis Res Ther."},{"key":"52617_CR7","doi-asserted-by":"publisher","first-page":"101902","DOI":"10.1016\/j.isci.2020.101902","volume":"24","author":"B Shi","year":"2021","unstructured":"Shi, B. et al. Targeting CD38-dependent NAD(+) metabolism to mitigate multiple organ fibrosis. iScience 24, 101902 (2021).","journal-title":"iScience"},{"key":"52617_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","volume":"345","author":"P Aksoy","year":"2006","unstructured":"Aksoy, P., White, T. A., Thompson, M. & Chini, E. N. Regulation of intracellular levels of NAD: a novel role for CD38. Biochem Biophys. Res Commun. 345, 1386\u20131392 (2006).","journal-title":"Biochem Biophys. Res Commun."},{"key":"52617_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1042\/bj3620125","volume":"362","author":"EN Chini","year":"2002","unstructured":"Chini, E. N., Chini, C. C., Kato, I., Takasawa, S. & Okamoto, H. CD38 is the major enzyme responsible for synthesis of nicotinic acid-adenine dinucleotide phosphate in mammalian tissues. Biochem J. 362, 125\u2013130 (2002).","journal-title":"Biochem J."},{"key":"52617_CR10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s42255-020-00305-3","volume":"2","author":"AJ Covarrubias","year":"2020","unstructured":"Covarrubias, A. J. et al. Senescent cells promote tissue NAD(+) decline during ageing via the activation of CD38(+) macrophages. Nat. Metab. 2, 1265\u20131283 (2020).","journal-title":"Nat. Metab."},{"key":"52617_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s42255-020-00298-z","volume":"2","author":"CCS Chini","year":"2020","unstructured":"Chini, C. C. S. et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD(+) and NMN levels. Nat. Metab. 2, 1284\u20131304 (2020).","journal-title":"Nat. Metab."},{"key":"52617_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.celrep.2019.12.014","volume":"30","author":"E Katsuyama","year":"2020","unstructured":"Katsuyama, E. et al. The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep. 30, 112\u2013123.e114 (2020).","journal-title":"Cell Rep."},{"key":"52617_CR13","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","volume":"383","author":"L Ostendorf","year":"2020","unstructured":"Ostendorf, L. et al. Targeting CD38 with Daratumumab in refractory systemic lupus erythematosus. N. Engl. J. Med. 383, 1149\u20131155 (2020).","journal-title":"N. Engl. J. Med"},{"key":"52617_CR14","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/s41591-023-02479-1","volume":"29","author":"D Roccatello","year":"2023","unstructured":"Roccatello, D. et al. Daratumumab monotherapy for refractory lupus nephritis. Nat. Med. 29, 2041\u20132047 (2023).","journal-title":"Nat. Med"},{"key":"52617_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/ard-2023-224152","volume":"82","author":"T Alexander","year":"2023","unstructured":"Alexander, T. et al. Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus. Ann. Rheum. Dis. 82, 1497\u20131499 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"52617_CR16","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1096\/fj.07-8290com","volume":"21","author":"MT Barbosa","year":"2007","unstructured":"Barbosa, M. T. et al. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J. 21, 3629\u20133639 (2007).","journal-title":"FASEB J."},{"key":"52617_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/jcmm.13297","volume":"22","author":"LF Wang","year":"2018","unstructured":"Wang, L. F. et al. CD38 deficiency suppresses adipogenesis and lipogenesis in adipose tissues through activating Sirt1\/PPARgamma signaling pathway. J. Cell Mol. Med. 22, 101\u2013110 (2018).","journal-title":"J. Cell Mol. Med"},{"key":"52617_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13683","volume":"7","author":"M Angela","year":"2016","unstructured":"Angela, M. et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARgamma directs early activation of T cells. Nat. Commun. 7, 13683 (2016).","journal-title":"Nat. Commun."},{"key":"52617_CR19","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.1302985","volume":"192","author":"J Lee","year":"2014","unstructured":"Lee, J. et al. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J. Immunol. 192, 3190\u20133199 (2014).","journal-title":"J. Immunol."},{"key":"52617_CR20","doi-asserted-by":"publisher","first-page":"11658","DOI":"10.1074\/jbc.275.16.11658","volume":"275","author":"A Prinetti","year":"2000","unstructured":"Prinetti, A., Chigorno, V., Tettamanti, G. & Sonnino, S. Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture. A compositional study. J. Biol. Chem. 275, 11658\u201311665 (2000).","journal-title":"J. Biol. Chem."},{"key":"52617_CR21","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.4049\/jimmunol.172.12.7821","volume":"172","author":"S Krishnan","year":"2004","unstructured":"Krishnan, S. et al. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J. Immunol. 172, 7821\u20137831 (2004).","journal-title":"J. Immunol."},{"key":"52617_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1172\/JCI69571","volume":"124","author":"G McDonald","year":"2014","unstructured":"McDonald, G. et al. Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients. J. Clin. Invest 124, 712\u2013724 (2014).","journal-title":"J. Clin. Invest"},{"key":"52617_CR23","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.4049\/jimmunol.177.10.7416","volume":"177","author":"EC Jury","year":"2006","unstructured":"Jury, E. C., Isenberg, D. A., Mauri, C. & Ehrenstein, M. R. Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus. J. Immunol. 177, 7416\u20137422 (2006).","journal-title":"J. Immunol."},{"key":"52617_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cyto.2013.02.023","volume":"62","author":"EJ Pavon","year":"2013","unstructured":"Pavon, E. J. et al. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Cytokine 62, 232\u2013243 (2013).","journal-title":"Cytokine"},{"key":"52617_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun, Y. A. & Obeid, L. M. Sphingolipids and their metabolism in physiology and disease. Nat. Rev. Mol. Cell Biol. 19, 175\u2013191 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"52617_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1083\/jcb.200207096","volume":"160","author":"N Tanimura","year":"2003","unstructured":"Tanimura, N. et al. Dynamic changes in the mobility of LAT in aggregated lipid rafts upon T cell activation. J. Cell Biol. 160, 125\u2013135 (2003).","journal-title":"J. Cell Biol."},{"key":"52617_CR27","doi-asserted-by":"publisher","first-page":"xi","DOI":"10.1093\/oxfordjournals.glycob.a018822","volume":"8","author":"S Hakomori","year":"1998","unstructured":"Hakomori, S., Handa, K., Iwabuchi, K., Yamamura, S. & Prinetti, A. New insights in glycosphingolipid function: \u201cglycosignaling domain,\u201d a cell surface assembly of glycosphingolipids with signal transducer molecules,involved in cell adhesion coupled with signaling. Glycobiology 8, xi\u2013xix (1998).","journal-title":"Glycobiology"},{"key":"52617_CR28","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1093\/glycob\/cwl052","volume":"17","author":"S Sonnino","year":"2007","unstructured":"Sonnino, S., Mauri, L., Chigorno, V. & Prinetti, A. Gangliosides as components of lipid membrane domains. Glycobiology 17, 1R\u201313R (2007).","journal-title":"Glycobiology"},{"key":"52617_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/0008-8749(88)90104-9","volume":"111","author":"DS Hoon","year":"1988","unstructured":"Hoon, D. S., Irie, R. F. & Cochran, A. J. Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2. Cell Immunol. 111, 410\u2013419 (1988).","journal-title":"Cell Immunol."},{"key":"52617_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1074\/jbc.RA118.004485","volume":"294","author":"A Banerjee","year":"2019","unstructured":"Banerjee, A., Mahata, B., Dhir, A., Mandal, T. K. & Biswas, K. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma. J. Biol. Chem. 294, 1005\u20131018 (2019).","journal-title":"J. Biol. Chem."},{"key":"52617_CR31","doi-asserted-by":"publisher","first-page":"30661","DOI":"10.18632\/oncotarget.25771","volume":"9","author":"K Rifai","year":"2018","unstructured":"Rifai, K. et al. SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer. Oncotarget 9, 30661\u201330678 (2018).","journal-title":"Oncotarget"},{"key":"52617_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S1074-7613(00)80659-7","volume":"9","author":"TS Finco","year":"1998","unstructured":"Finco, T. S., Kadlecek, T., Zhang, W., Samelson, L. E. & Weiss, A. LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway. Immunity 9, 617\u2013626 (1998).","journal-title":"Immunity"},{"key":"52617_CR33","doi-asserted-by":"publisher","first-page":"28861","DOI":"10.1074\/jbc.274.41.28861","volume":"274","author":"J Lin","year":"1999","unstructured":"Lin, J., Weiss, A. & Finco, T. S. Localization of LAT in glycolipid-enriched microdomains is required for T cell activation. J. Biol. Chem. 274, 28861\u201328864 (1999).","journal-title":"J. Biol. Chem."},{"key":"52617_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah, K., Al-Haidari, A., Sun, J. & Kazi, J. U. T cell receptor (TCR) signaling in health and disease. Signal Transduct. Target Ther. 6, 412 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"52617_CR35","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B","volume":"44","author":"EJ Enyedy","year":"2001","unstructured":"Enyedy, E. J. et al. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum. 44, 1114\u20131121 (2001).","journal-title":"Arthritis Rheum."},{"key":"52617_CR36","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1172\/JCI87037","volume":"126","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus. J. Clin. Invest 126, 2077\u20132092 (2016).","journal-title":"J. Clin. Invest"},{"key":"52617_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","volume":"391","author":"ZW Lai","year":"2018","unstructured":"Lai, Z. W. et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial. Lancet 391, 1186\u20131196 (2018).","journal-title":"Lancet"},{"key":"52617_CR38","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1172\/JCI1457","volume":"101","author":"SN Liossis","year":"1998","unstructured":"Liossis, S. N., Ding, X. Z., Dennis, G. J. & Tsokos, G. C. Altered pattern of TCR\/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest 101, 1448\u20131457 (1998).","journal-title":"J. Clin. Invest"},{"key":"52617_CR39","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.4049\/jimmunol.155.4.2269","volume":"155","author":"D Vassilopoulos","year":"1995","unstructured":"Vassilopoulos, D., Kovacs, B. & Tsokos, G. C. TCR\/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol. 155, 2269\u20132281 (1995).","journal-title":"J. Immunol."},{"key":"52617_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature05122","volume":"443","author":"M Prakriya","year":"2006","unstructured":"Prakriya, M. et al. Orai1 is an essential pore subunit of the CRAC channel. Nature 443, 230\u2013233 (2006).","journal-title":"Nature"},{"key":"52617_CR41","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.8235624","volume":"262","author":"M Howard","year":"1993","unstructured":"Howard, M. et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 262, 1056\u20131059 (1993).","journal-title":"Science"},{"key":"52617_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/18024","volume":"398","author":"AH Guse","year":"1999","unstructured":"Guse, A. H. et al. Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose. Nature 398, 70\u201373 (1999).","journal-title":"Nature"},{"key":"52617_CR43","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nri2152","volume":"7","author":"S Feske","year":"2007","unstructured":"Feske, S. Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol. 7, 690\u2013702 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"52617_CR44","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.cub.2014.04.046","volume":"24","author":"P Kar","year":"2014","unstructured":"Kar, P. et al. Dynamic assembly of a membrane signaling complex enables selective activation of NFAT by Orai1. Curr. Biol. 24, 1361\u20131368 (2014).","journal-title":"Curr. Biol."},{"key":"52617_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.molcel.2015.02.027","volume":"58","author":"P Kar","year":"2015","unstructured":"Kar, P. & Parekh, A. B. Distinct spatial Ca2+ signatures selectively activate different NFAT transcription factor isoforms. Mol. Cell 58, 232\u2013243 (2015).","journal-title":"Mol. Cell"},{"key":"52617_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrd.2018.148","volume":"17","author":"A Sharabi","year":"2018","unstructured":"Sharabi, A. et al. Regulatory T cells in the treatment of disease. Nat. Rev. Drug Discov. 17, 823\u2013844 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52617_CR47","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.4049\/jimmunol.130.6.2651","volume":"130","author":"M Linker-Israeli","year":"1983","unstructured":"Linker-Israeli, M. et al. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 130, 2651\u20132655 (1983).","journal-title":"J. Immunol."},{"key":"52617_CR48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","volume":"3","author":"DM Willerford","year":"1995","unstructured":"Willerford, D. M. et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521\u2013530 (1995).","journal-title":"Immunity"},{"key":"52617_CR49","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/cdd.2010.142","volume":"18","author":"L Bouman","year":"2011","unstructured":"Bouman, L. et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ. 18, 769\u2013782 (2011).","journal-title":"Cell Death Differ."},{"key":"52617_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma, X. et al. Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment. Cell Metab. 30, 143\u2013156.e145 (2019).","journal-title":"Cell Metab."},{"key":"52617_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-018-0597-x","volume":"562","author":"M Song","year":"2018","unstructured":"Song, M. et al. IRE1alpha-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature 562, 423\u2013428 (2018).","journal-title":"Nature"},{"key":"52617_CR52","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nrd2755","volume":"7","author":"I Kim","year":"2008","unstructured":"Kim, I., Xu, W. & Reed, J. C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7, 1013\u20131030 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52617_CR53","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.4049\/jimmunol.181.6.4019","volume":"181","author":"GM Deng","year":"2008","unstructured":"Deng, G. M. & Tsokos, G. C. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. J. Immunol. 181, 4019\u20134026 (2008).","journal-title":"J. Immunol."},{"key":"52617_CR54","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI22854","volume":"115","author":"YT Juang","year":"2005","unstructured":"Juang, Y. T. et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Invest 115, 996\u20131005 (2005).","journal-title":"J. Clin. Invest"},{"key":"52617_CR55","doi-asserted-by":"publisher","first-page":"E336","DOI":"10.1073\/pnas.1114965109","volume":"109","author":"M Nagafuku","year":"2012","unstructured":"Nagafuku, M. et al. CD4 and CD8 T cells require different membrane gangliosides for activation. Proc. Natl Acad. Sci. USA 109, E336\u2013E342 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"52617_CR56","doi-asserted-by":"publisher","first-page":"14787","DOI":"10.1074\/jbc.M111.218610","volume":"286","author":"Y Zhu","year":"2011","unstructured":"Zhu, Y. et al. Lowering glycosphingolipid levels in CD4+ T cells attenuates T cell receptor signaling, cytokine production, and differentiation to the Th17 lineage. J. Biol. Chem. 286, 14787\u201314794 (2011).","journal-title":"J. Biol. Chem."},{"key":"52617_CR57","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/BJ20061061","volume":"402","author":"C Barbat","year":"2007","unstructured":"Barbat, C. et al. p56lck, LFA-1 and PI3K but not SHP-2 interact with GM1- or GM3-enriched microdomains in a CD4-p56lck association-dependent manner. Biochem J. 402, 471\u2013481 (2007).","journal-title":"Biochem J."},{"key":"52617_CR58","doi-asserted-by":"publisher","first-page":"e2017394118","DOI":"10.1073\/pnas.2017394118","volume":"118","author":"KE Waddington","year":"2021","unstructured":"Waddington, K. E. et al. LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function. Proc. Natl Acad. Sci. USA 118, e2017394118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"52617_CR59","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10067-014-2654-7","volume":"33","author":"A Fatemi","year":"2014","unstructured":"Fatemi, A. et al. Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial. Clin. Rheumatol. 33, 1273\u20131278 (2014).","journal-title":"Clin. Rheumatol."},{"key":"52617_CR60","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00296-007-0341-6","volume":"27","author":"KH Costenbader","year":"2007","unstructured":"Costenbader, K. H. et al. A pravastatin dose-escalation study in systemic lupus erythematosus. Rheumatol. Int 27, 1071\u20131077 (2007).","journal-title":"Rheumatol. Int"},{"key":"52617_CR61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0021-9150(99)00462-1","volume":"152","author":"AC Knapp","year":"2000","unstructured":"Knapp, A. C., Huang, J., Starling, G. & Kiener, P. A. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis 152, 217\u2013227 (2000).","journal-title":"Atherosclerosis"},{"key":"52617_CR62","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/82219","volume":"6","author":"B Kwak","year":"2000","unstructured":"Kwak, B., Mulhaupt, F., Myit, S. & Mach, F. Statins as a newly recognized type of immunomodulator. Nat. Med 6, 1399\u20131402 (2000).","journal-title":"Nat. Med"},{"key":"52617_CR63","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1073\/pnas.1302825110","volume":"110","author":"YJ Liang","year":"2013","unstructured":"Liang, Y. J. et al. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. Proc. Natl Acad. Sci. USA 110, 4968\u20134973 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"52617_CR64","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/1097-0142(19950315)75:6<1273::AID-CNCR2820750609>3.0.CO;2-O","volume":"75","author":"Y Yuyama","year":"1995","unstructured":"Yuyama, Y., Dohi, T., Morita, H., Furukawa, K. & Oshima, M. Enhanced expression of GM2\/GD2 synthase mRNA in human gastrointestinal cancer. Cancer 75, 1273\u20131280 (1995).","journal-title":"Cancer"},{"key":"52617_CR65","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S0960-9822(03)00531-1","volume":"13","author":"MC Gondre-Lewis","year":"2003","unstructured":"Gondre-Lewis, M. C., McGlynn, R. & Walkley, S. U. Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent. Curr. Biol. 13, 1324\u20131329 (2003).","journal-title":"Curr. Biol."},{"key":"52617_CR66","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1471-4906(03)00100-5","volume":"24","author":"GC Tsokos","year":"2003","unstructured":"Tsokos, G. C., Nambiar, M. P., Tenbrock, K. & Juang, Y. T. Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE. Trends Immunol. 24, 259\u2013263 (2003).","journal-title":"Trends Immunol."},{"key":"52617_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ceca.2009.11.001","volume":"47","author":"SA Nicolaou","year":"2010","unstructured":"Nicolaou, S. A. et al. Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus. Cell Calcium 47, 19\u201328 (2010).","journal-title":"Cell Calcium"},{"key":"52617_CR68","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature04702","volume":"441","author":"S Feske","year":"2006","unstructured":"Feske, S. et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179\u2013185 (2006).","journal-title":"Nature"},{"key":"52617_CR69","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cmet.2019.01.019","volume":"29","author":"U Kaufmann","year":"2019","unstructured":"Kaufmann, U. et al. Calcium signaling controls pathogenic Th17 cell-mediated inflammation by regulating mitochondrial function. Cell Metab. 29, 1104\u20131118.e1106 (2019).","journal-title":"Cell Metab."},{"key":"52617_CR70","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2741\/e540","volume":"4","author":"PJ Shaw","year":"2012","unstructured":"Shaw, P. J. & Feske, S. Physiological and pathophysiological functions of SOCE in the immune system. Front Biosci. (Elite Ed.) 4, 2253\u20132268 (2012).","journal-title":"Front Biosci. (Elite Ed.)"},{"key":"52617_CR71","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.4049\/jimmunol.1800810","volume":"201","author":"E Katsuyama","year":"2018","unstructured":"Katsuyama, E. et al. Correction: downregulation of miR-200a-3p, targeting CtBP2 complex, is involved in the hypoproduction of IL-2 in systemic lupus erythematosus-derived T cells. J. Immunol. 201, 1104 (2018).","journal-title":"J. Immunol."},{"key":"52617_CR72","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/268154a0","volume":"268","author":"S Gillis","year":"1977","unstructured":"Gillis, S. & Smith, K. A. Long term culture of tumour-specific cytotoxic T cells. Nature 268, 154\u2013156 (1977).","journal-title":"Nature"},{"key":"52617_CR73","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1084\/jem.148.4.1093","volume":"148","author":"S Gillis","year":"1978","unstructured":"Gillis, S., Baker, P. E., Ruscetti, F. W. & Smith, K. A. Long-term culture of human antigen-specific cytotoxic T-cell lines. J. Exp. Med. 148, 1093\u20131098 (1978).","journal-title":"J. Exp. Med"},{"key":"52617_CR74","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41584-021-00707-x","volume":"17","author":"AGA Kolios","year":"2021","unstructured":"Kolios, A. G. A., Tsokos, G. C. & Klatzmann, D. Interleukin-2 and regulatory T cells in rheumatic diseases. Nat. Rev. Rheumatol. 17, 749\u2013766 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"52617_CR75","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan, E. M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271\u20131277 (1982).","journal-title":"Arthritis Rheum."},{"key":"52617_CR76","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D. & Chang, C. H. Derivation of the SLEDAI. a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35, 630\u2013640 (1992).","journal-title":"Arthritis Rheum."},{"key":"52617_CR77","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"},{"key":"52617_CR78","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"52617_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"52617_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52617-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52617-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52617-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T16:03:10Z","timestamp":1727712190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52617-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52617"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52617-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"11 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GCT is on the scientific advisory boards of Cugene, Biolojic, ABPRO, A2 biotherapeutics, COREVITAS. VCK is site PI for clinical trial for BMS, Astra Zeneca and Novartis. VK is advisory board member for Janssen and Aurinia. VK is in the clinical trial adjudication committee member for Cabaletta. ASF currently employed at Abbvie. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8304"}}